217 related articles for article (PubMed ID: 14606928)
1. Once-daily administration of antiretrovirals: pharmacokinetics of emerging therapies.
Taburet AM; Paci-Bonaventure S; Peytavin G; Molina JM
Clin Pharmacokinet; 2003; 42(14):1179-91. PubMed ID: 14606928
[TBL] [Abstract][Full Text] [Related]
2. Once-daily therapies.
Carey D
J HIV Ther; 2003 Feb; 8(1):7-11. PubMed ID: 12840708
[TBL] [Abstract][Full Text] [Related]
3. Simplifying drug regimens.
HIV Hotline; 1998 Mar; 8(1):11. PubMed ID: 11365353
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic study of dual therapy with raltegravir 400 mg twice daily and Darunavir/Ritonavir 800/100 mg once daily in HIV-1-infected patients.
Martínez-Rebollar M; Muñoz A; Pérez I; Hidalgo S; Brunet M; Laguno M; González A; Calvo M; Loncà M; Blanco JL; Martínez E; Gatell JM; Mallolas J
Ther Drug Monit; 2013 Aug; 35(4):552-6. PubMed ID: 23851911
[TBL] [Abstract][Full Text] [Related]
5. Daily dosing of highly active antiretroviral therapy.
Rosenbach KA; Allison R; Nadler JP
Clin Infect Dis; 2002 Mar; 34(5):686-92. PubMed ID: 11823957
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral adherence and pharmacokinetics: review of their roles in sustained virologic suppression.
Pham PA
AIDS Patient Care STDS; 2009 Oct; 23(10):803-7. PubMed ID: 19795999
[TBL] [Abstract][Full Text] [Related]
7. Simplification strategies to reduce antiretroviral drug exposure: progress and prospects.
McKinnon JE; Mellors JW; Swindells S
Antivir Ther; 2009; 14(1):1-12. PubMed ID: 19320232
[TBL] [Abstract][Full Text] [Related]
8. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.
Joly V; Yeni P
Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761
[TBL] [Abstract][Full Text] [Related]
9. The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients.
Garvey L; Latch N; Erlwein OW; Mackie NE; Walsh J; Scullard G; McClure MO; Dickinson L; Back D; Winston A
Antivir Ther; 2010; 15(2):213-8. PubMed ID: 20386076
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of boosted once-daily darunavir.
Kakuda TN; Brochot A; Tomaka FL; Vangeneugden T; Van De Casteele T; Hoetelmans RM
J Antimicrob Chemother; 2014 Oct; 69(10):2591-605. PubMed ID: 24951533
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of antiretroviral drugs.
Hoetelmans RM
Antivir Ther; 1999; 4 Suppl 3():29-41. PubMed ID: 16021869
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of antiretrovirals in pregnant women.
Mirochnick M; Capparelli E
Clin Pharmacokinet; 2004; 43(15):1071-87. PubMed ID: 15568888
[TBL] [Abstract][Full Text] [Related]
13. A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study).
Burger DM; Aarnoutse RE; Dieleman JP; Gyssens IC; Nouwen J; de Marie S; Koopmans PP; Stek M; van der Ende ME
Antivir Ther; 2003 Oct; 8(5):455-61. PubMed ID: 14640393
[TBL] [Abstract][Full Text] [Related]
14. The Place of protease inhibitors in antiretroviral treatment.
Tenore SB; Ferreira PR
Braz J Infect Dis; 2009 Oct; 13(5):371-4. PubMed ID: 20428639
[TBL] [Abstract][Full Text] [Related]
15. Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.
Swindells S; DiRienzo AG; Wilkin T; Fletcher CV; Margolis DM; Thal GD; Godfrey C; Bastow B; Ray MG; Wang H; Coombs RW; McKinnon J; Mellors JW;
JAMA; 2006 Aug; 296(7):806-14. PubMed ID: 16905786
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral pharmacokinetics in the paediatric population: a review.
King JR; Kimberlin DW; Aldrovandi GM; Acosta EP
Clin Pharmacokinet; 2002; 41(14):1115-33. PubMed ID: 12405863
[TBL] [Abstract][Full Text] [Related]
17. [Role of etravirine in combination antiretroviral therapy].
Domingo P
Enferm Infecc Microbiol Clin; 2009 Dec; 27 Suppl 2():46-51. PubMed ID: 20116628
[TBL] [Abstract][Full Text] [Related]
18. Once-daily therapies for the treatment of HIV infection.
Tashima KT; Mitty JA
Curr HIV/AIDS Rep; 2006 Jul; 3(2):86-92. PubMed ID: 16608665
[TBL] [Abstract][Full Text] [Related]
19. Simplifying antiretroviral therapy.
Tapper ML; Flexner C; Eron JJ; Molina JM
AIDS Read; 2004 Jul; 14(7):355-60, 367-71. PubMed ID: 15282865
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?
Ribera E; López-Cortés LF; Soriano V; Casado JL; Mallolas J
Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():41-67. PubMed ID: 16373004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
